Why is ULT capacity more common in Belgium?

Because vaccine and biologics manufacturing and clinical trial logistics are concentrated there. That pulls −70/−80 °C requirements into projects that in other markets would only need +2/+8 °C, and it raises expectations around backup injection, independent monitoring and documented transfer plans.

What drives cost in a Belgian pharma cold storage project?

Band structure first — an ULT zone can cost several times a chilled zone per m². Then redundancy level, validation scope, and whether the facility must sustain high-frequency handling, which forces investment in airlocks, fast doors and staging areas rather than in raw capacity.

How should airport-linked handling facilities be specified?

Around excursion control rather than holding capacity: staging area temperature, maximum permitted exposure during transfer, dock and airlock design, monitoring continuity across handovers, and the documented procedure when a shipment breaches its band. Storage volume alone is the wrong specification for these facilities.

In which language should a Belgian pharma RFQ be issued?

Pick one and be consistent. English works across both regions for technical bid packs, with Dutch or French for commercial and site-facing documents. What causes disputes is a specification part-translated across languages where terms drift.

Who supervises pharmaceutical distribution in Belgium?

The Federal Agency for Medicines and Health Products (FAMHP / AFMPS / FAGG) supervises medicines distribution within the EU GDP framework. Regulatory interpretation belongs to your quality function and the agency; this page addresses planning only.

Offline — reconnect before saving or submitting. Changes on this page have not been sent.

Belgium · pharma corridor

Pharmaceutical Cold Storage and Warehouse Cooling in Belgium

Belgium combines large-scale biologics and vaccine manufacturing with one of the world's densest air-freight pharma corridors. The result is a market where both deep validated storage and fast-turnaround handling capacity are procured — often on the same site — and where ULT capability is more common than country size suggests.

Direct answers for project buyers

Pharmaceutical cold storage in Belgium is planned around a roughly 30–32 °C summer design condition, a mature validated-storage supplier base, and two distinct project types: manufacturer and CDMO storage attached to biologics production (including significant ULT demand), and airport-linked handling facilities where turnaround speed and excursion control dominate the design.

Build Your Pharmaceutical Cooling Project Brief Calculate Your Pharma Cold Room Requirement

The market in context

Vaccine and biologics manufacturing gives Belgium unusually high ULT and −20 °C demand relative to its size, alongside conventional +2/+8 °C capacity.

The Brussels Airport pharma corridor drives a second project type: handling and staging facilities where the design problem is protecting product across short, frequent movements rather than long-term holding.

Bilingual procurement is normal — Dutch in Flanders, French in Wallonia and Brussels — and RFQ documents circulate in English between them. Specify in one language and state it; mixed-language specifications create scope disputes.

The engineering and installation supplier base is deep and internationally experienced, so competitive bidding works well when the specification is precise.

Planning parameters

Summer ambient design: ≈ 30–32 °C dry bulb
Electricity (commercial, indicative): ≈ EUR 0.16–0.28 / kWh
Typical bands: +15/+25 °C CRT, +2/+8 °C, −20 °C, −70/−80 °C ULT (well represented)
Second project type: Airport-linked handling and staging with rapid turnaround
Redundancy norm: N+1 minimum; 2N and backup injection common on ULT
Procurement note: Dutch / French / English — fix one specification language
Minimum project size: ColdMatch reviews projects from about USD $250K; smaller enquiries receive guidance only
Routine reporting: Set excursion reports, alarm review, calibration intervals and service cadence before award

Direct answers for project buyers

How is a mixed +2/+8 °C and ULT facility planned?

Treat them as separate systems that share a building, not as one plant with different setpoints. ULT needs cascade or two-stage plant, its own backup strategy (spare units or backup injection), its own monitoring and its own plant-room condition. Sharing condensing capacity across bands to save money usually costs more in complexity and risk than it saves.

What belongs in a Belgian pharma RFQ that is often left out?

Transfer and excursion procedures, the interface between refrigeration scope and building scope, monitoring continuity across handovers, and the service response commitment with a stated response time. These are the items that decide whether the facility actually performs after handover.

Manufacturer storage or contracted GDP capacity?

Contracted capacity suits variable and short-horizon volume, especially for ULT where investment per litre is high. Owned storage suits stable volume and product that must stay under direct control. Compare on cost per pallet position per year including validation and monitoring, not on CAPEX alone.

Typical project scale

CDMO or manufacturer suite: 100–800 m² multi-band
Distribution and staging facility: 800–5,000 m²
Biologics campus: dedicated ULT zone plus chilled and frozen areas

How this project is usually structured

1Belgium
2Biologics manufacturer / airport-linked handling facility
3+2/+8 °C and −70/−80 °C ULT zones
4Separate plant per band, N+1 with backup injection
5Cooling load → redundancy planner → TCO
6Structured pharmaceutical RFQ

Tools for this project

Pharmaceutical cold room calculator Pharma cold storage energy calculator Refrigeration redundancy planner Total cost of ownership calculator Cold chain Belgium Ultra-low temperature storage Vaccine cold storage Build a pharmaceutical RFQ

How ColdMatch Group works — independent B2B procurement and sourcing platform — ColdMatch Group is an independent B2B procurement and sourcing platform for industrial refrigeration, cold storage and cold-chain projects from USD $250K+, where the ColdMatch team reviews each buyer brief, contacts suitable third-party suppliers on the buyer's behalf and organizes their responses.

References

ColdMatch Group is an independent, supplier-neutral B2B procurement and RFQ platform. Our team reviews serious project briefs before any supplier research or outreach. We do not provide final refrigeration design, engineering or regulatory approval, certification, financing or supplier guarantees. Planning figures require review by qualified specialists and local authorities.

Continue your European procurement research

Move from market research to project sizing, a structured brief and comparable supplier proposals.